Nifty

:

15803.90

Sensex

:

52742.22

25.45 (0.16%)
89.15 (0.17%)

Login

Nifty
Sensex

:
:

15803.90
52742.22

25.45 (0.16%)
89.15 (0.17%)

Bal Pharma Ltd.

Pharmaceuticals & Drugs

Rating :

43/99

BSE: 524824 | NSE: BALPHARMA

Watchlist

NSE BSE

94.80

29-Jul-2021

Open
High
Low
Previous Close

93.15
96.45
93.15
94.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

11537
10.96
137.70
39.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

140.59
246.65
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

255.91
N/A
1.90

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.08
-2.89
-6.33

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-4.18
-16.33
-21.04

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

21.72
29.37
13.88

P:BV (Average)

8 Years
5 Years
3 Years

1.63
1.68
1.42

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.19
13.00
13.08

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 0.00 33.77 -100.00% 62.70 43.00 45.81% 64.28 44.74 43.67% 52.05 49.17 5.86%
Expenses 0.00 32.97 -100.00% 56.47 41.27 36.83% 56.87 42.85 32.72% 46.33 47.32 -2.09%
EBITDA 0.00 0.79 -100.00% 6.23 1.73 260.12% 7.41 1.89 292.06% 5.72 1.84 210.87%
EBIDTM 0.00% 2.35% 9.94% 4.03% 11.53% 4.22% 10.99% 3.75%
Other Income 0.00 1.62 -100.00% 0.64 0.98 -34.69% 0.39 0.41 -4.88% 0.49 0.60 -18.33%
Interest 0.00 3.00 -100.00% 2.89 2.80 3.21% 3.17 3.32 -4.52% 2.78 3.29 -15.50%
Depreciation 0.00 3.03 -100.00% 1.64 1.35 21.48% 1.80 1.33 35.34% 1.49 1.31 13.74%
PBT 0.00 -3.62 - 2.35 -1.44 - 2.84 -2.35 - 1.93 -2.16 -
Tax 0.00 0.53 -100.00% 0.80 0.57 40.35% 1.31 -0.77 - 0.29 -0.37 -
PAT 0.00 -4.15 - 1.55 -2.01 - 1.53 -1.58 - 1.64 -1.79 -
PATM 0.00% -12.28% 2.47% -4.67% 2.38% -3.53% 3.15% -3.65%
EPS 0.00 -2.80 - 1.05 -1.36 - 1.03 -1.07 - 1.11 -1.21 -

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 0.00 33.77 -100.00% 63.03 43.17 46.00% 64.56 44.99 43.50% 52.13 49.16 6.04%
Expenses 0.00 33.14 -100.00% 57.10 42.47 34.45% 57.46 43.15 33.16% 47.05 47.57 -1.09%
EBITDA 0.00 0.63 -100.00% 5.93 0.70 747.14% 7.10 1.83 287.98% 5.08 1.59 219.50%
EBIDTM 0.00% 1.87% 9.41% 1.63% 11.00% 4.07% 9.75% 3.24%
Other Income 0.00 1.17 -100.00% 0.19 0.41 -53.66% 0.06 0.03 100.00% 0.16 0.23 -30.43%
Interest 0.00 3.02 -100.00% 2.89 2.81 2.85% 3.19 3.33 -4.20% 2.79 3.29 -15.20%
Depreciation 0.00 3.59 -100.00% 2.03 1.42 42.96% 2.17 1.35 60.74% 1.88 1.32 42.42%
PBT 0.00 -4.80 - 1.20 -3.11 - 1.81 -2.83 - 0.57 -2.79 -
Tax 0.00 -0.07 - 0.80 0.60 33.33% 1.31 -0.84 - 0.29 -0.33 -
PAT 0.00 -4.74 - 0.40 -3.71 - 0.50 -1.99 - 0.28 -2.46 -
PATM 0.00% -14.02% 0.64% -8.58% 0.77% -4.42% 0.54% -5.01%
EPS 0.00 -3.34 - 0.22 -2.52 - 0.30 -1.29 - 0.30 -1.62 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 212.80 170.67 223.08 207.66 225.96 197.66 187.13 178.87 147.91 139.69 114.44 Net Sales Growth 10.19% -23.49% 7.43% -8.10% 14.32% 5.63% 4.62% 20.93% 5.88% 22.06% Cost Of Goods Sold 124.19 75.35 103.69 87.91 103.73 93.97 87.48 83.74 68.88 67.24 54.71 Gross Profit 88.61 95.33 119.39 119.74 122.24 103.69 99.65 95.14 79.03 72.45 59.73 GP Margin 41.64% 55.86% 53.52% 57.66% 54.10% 52.46% 53.25% 53.19% 53.43% 51.86% 52.19% Total Expenditure 192.64 163.64 202.59 184.76 205.85 180.52 169.60 161.00 130.70 124.88 103.66 Power & Fuel Cost - 4.68 6.38 6.06 6.17 4.65 4.54 4.39 3.52 3.50 2.71 % Of Sales - 2.74% 2.86% 2.92% 2.73% 2.35% 2.43% 2.45% 2.38% 2.51% 2.37% Employee Cost - 48.77 48.45 49.61 41.35 35.67 31.96 28.12 23.65 21.15 18.14 % Of Sales - 28.58% 21.72% 23.89% 18.30% 18.05% 17.08% 15.72% 15.99% 15.14% 15.85% Manufacturing Exp. - 15.94 20.42 17.99 21.25 19.69 20.77 18.23 14.03 14.86 11.98 % Of Sales - 9.34% 9.15% 8.66% 9.40% 9.96% 11.10% 10.19% 9.49% 10.64% 10.47% General & Admin Exp. - 7.09 8.61 10.26 16.08 13.69 12.31 11.54 9.40 8.44 7.29 % Of Sales - 4.15% 3.86% 4.94% 7.12% 6.93% 6.58% 6.45% 6.36% 6.04% 6.37% Selling & Distn. Exp. - 10.59 13.71 12.64 16.41 12.36 11.88 13.49 10.82 9.09 8.71 % Of Sales - 6.20% 6.15% 6.09% 7.26% 6.25% 6.35% 7.54% 7.32% 6.51% 7.61% Miscellaneous Exp. - 1.22 1.32 0.27 0.86 0.47 0.65 1.48 0.38 0.61 8.71 % Of Sales - 0.71% 0.59% 0.13% 0.38% 0.24% 0.35% 0.83% 0.26% 0.44% 0.10% EBITDA 20.15 7.03 20.49 22.90 20.11 17.14 17.53 17.87 17.21 14.81 10.78 EBITDA Margin 9.47% 4.12% 9.19% 11.03% 8.90% 8.67% 9.37% 9.99% 11.64% 10.60% 9.42% Other Income 3.14 3.62 2.75 1.67 3.39 1.50 1.19 0.65 0.66 1.08 0.54 Interest 11.84 12.69 12.71 9.39 8.46 6.48 6.52 7.16 7.98 7.39 6.79 Depreciation 7.96 7.03 6.12 6.73 6.46 6.97 7.00 4.74 4.81 4.13 3.42 PBT 3.50 -9.08 4.41 8.45 8.59 5.18 5.20 6.63 5.09 4.37 1.10 Tax 2.93 -0.17 -2.35 2.52 3.28 2.38 1.18 1.55 0.81 0.61 0.63 Tax Rate 83.71% 1.87% -53.29% 29.82% 38.18% 45.95% 22.69% 23.38% 15.91% 13.96% 57.27% PAT 0.57 -8.90 6.76 5.94 5.31 2.81 4.02 5.07 4.28 3.76 0.47 PAT before Minority Interest 0.57 -8.90 6.76 5.94 5.31 2.81 4.02 5.07 4.28 3.76 0.47 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.27% -5.21% 3.03% 2.86% 2.35% 1.42% 2.15% 2.83% 2.89% 2.69% 0.41% PAT Growth 131.49% - 13.80% 11.86% 88.97% -30.10% -20.71% 18.46% 13.83% 700.00% EPS 0.39 -6.01 4.57 4.01 3.59 1.90 2.72 3.43 2.89 2.54 0.32

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 11 Mar 10 Mar 09
Net Sales 213.49 171.09 225.01 209.29 228.91 198.32 187.16 178.87 114.29 106.23 103.60 Net Sales Growth 10.97% -23.96% 7.51% -8.57% 15.42% 5.96% 4.63% 56.51% 7.59% 2.54% Cost Of Goods Sold 122.59 75.25 104.04 88.57 103.94 94.06 87.49 83.74 54.71 55.24 48.46 Gross Profit 90.90 95.84 120.96 120.71 124.97 104.25 99.67 95.14 59.58 50.99 55.14 GP Margin 42.58% 56.02% 53.76% 57.68% 54.59% 52.57% 53.25% 53.19% 52.13% 48.00% 53.22% Total Expenditure 194.75 166.05 207.33 191.95 214.10 183.46 170.05 161.00 104.36 100.95 93.07 Power & Fuel Cost - 4.76 6.38 6.07 6.17 4.66 4.54 4.39 2.90 2.13 2.13 % Of Sales - 2.78% 2.84% 2.90% 2.70% 2.35% 2.43% 2.45% 2.54% 2.01% 2.06% Employee Cost - 50.43 50.28 52.16 45.37 37.30 32.24 28.12 20.58 19.73 20.37 % Of Sales - 29.48% 22.35% 24.92% 19.82% 18.81% 17.23% 15.72% 18.01% 18.57% 19.66% Manufacturing Exp. - 15.80 20.28 18.03 21.44 19.80 20.78 18.23 11.24 8.90 7.84 % Of Sales - 9.23% 9.01% 8.61% 9.37% 9.98% 11.10% 10.19% 9.83% 8.38% 7.57% General & Admin Exp. - 7.48 9.27 11.21 16.82 13.98 12.43 11.54 5.41 4.71 4.42 % Of Sales - 4.37% 4.12% 5.36% 7.35% 7.05% 6.64% 6.45% 4.73% 4.43% 4.27% Selling & Distn. Exp. - 11.11 15.74 15.63 19.50 13.18 11.91 13.49 8.73 9.62 8.90 % Of Sales - 6.49% 7.00% 7.47% 8.52% 6.65% 6.36% 7.54% 7.64% 9.06% 8.59% Miscellaneous Exp. - 1.23 1.33 0.27 0.86 0.47 0.65 1.48 0.78 0.62 8.90 % Of Sales - 0.72% 0.59% 0.13% 0.38% 0.24% 0.35% 0.83% 0.68% 0.58% 0.92% EBITDA 18.74 5.04 17.68 17.34 14.81 14.86 17.11 17.87 9.93 5.28 10.53 EBITDA Margin 8.78% 2.95% 7.86% 8.29% 6.47% 7.49% 9.14% 9.99% 8.69% 4.97% 10.16% Other Income 1.58 1.84 1.01 1.73 3.04 1.28 1.17 0.65 0.79 2.94 0.12 Interest 11.89 12.73 12.74 9.41 8.49 6.48 6.52 7.16 6.79 6.26 4.71 Depreciation 9.67 7.68 6.16 6.77 6.49 7.01 7.02 4.74 2.90 2.86 1.89 PBT -1.22 -13.53 -0.20 2.88 2.87 2.65 4.74 6.63 1.04 -0.91 4.06 Tax 2.33 -0.64 -2.36 2.51 3.27 2.39 1.19 1.55 0.63 0.52 1.06 Tax Rate -190.98% 4.73% 1180.00% 87.15% 113.94% 90.19% 25.11% 23.38% 60.58% -57.14% 26.11% PAT -3.56 -12.22 3.79 2.79 1.75 1.41 3.62 5.07 0.41 -1.43 2.99 PAT before Minority Interest -3.58 -12.89 2.15 0.38 -0.40 0.26 3.55 5.07 0.41 -1.43 2.99 Minority Interest -0.02 0.67 1.64 2.41 2.15 1.15 0.07 0.00 0.00 0.00 0.00 PAT Margin -1.67% -7.14% 1.68% 1.33% 0.76% 0.71% 1.93% 2.83% 0.36% -1.35% 2.89% PAT Growth 0.00% - 35.84% 59.43% 24.11% -61.05% -28.60% 1,136.59% - - EPS -2.41 -8.26 2.56 1.89 1.18 0.95 2.45 3.43 0.28 -0.97 2.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 65.94 76.86 72.23 66.59 56.70 55.60 50.05 44.62 40.06 36.51 Share Capital 14.17 14.17 14.17 14.17 12.87 12.87 11.11 10.57 10.57 10.48 Total Reserves 51.77 62.69 58.06 52.41 41.81 40.71 37.20 32.84 29.48 25.83 Non-Current Liabilities 33.42 37.24 45.53 29.94 26.02 16.33 17.92 12.55 14.79 20.23 Secured Loans 23.15 28.76 33.25 12.76 10.81 6.11 6.58 1.00 5.81 11.79 Unsecured Loans 0.00 0.00 1.43 5.04 5.13 0.53 1.39 0.67 0.28 0.00 Long Term Provisions 3.55 2.66 2.02 3.35 2.23 1.65 1.06 0.83 0.64 1.00 Current Liabilities 139.95 143.06 133.33 122.32 110.61 92.22 86.77 92.67 86.32 78.68 Trade Payables 39.45 47.49 49.95 53.55 46.75 38.49 33.53 32.06 26.92 26.21 Other Current Liabilities 29.40 26.55 31.73 15.42 11.53 11.77 8.66 14.97 13.96 10.74 Short Term Borrowings 70.61 68.06 49.29 52.05 50.09 40.14 42.75 44.36 44.53 41.25 Short Term Provisions 0.49 0.96 2.37 1.29 2.24 1.83 1.83 1.28 0.91 0.47 Total Liabilities 239.31 257.16 251.09 218.85 193.33 164.15 154.74 149.84 141.17 135.42 Net Block 56.14 56.94 58.28 59.72 55.95 51.90 55.18 51.83 52.90 53.93 Gross Block 82.36 76.19 71.43 66.14 105.77 96.00 91.28 83.19 79.49 75.78 Accumulated Depreciation 26.23 19.25 13.15 6.42 49.82 44.10 36.10 31.36 26.59 21.86 Non Current Assets 66.84 68.66 69.62 68.49 68.89 59.50 59.63 56.82 56.68 56.34 Capital Work in Progress 0.11 0.06 0.21 1.70 3.93 0.77 0.25 0.87 0.41 0.13 Non Current Investment 7.42 7.44 7.44 0.02 1.18 1.09 0.02 0.02 0.02 0.06 Long Term Loans & Adv. 1.62 1.68 3.13 6.59 7.52 5.39 3.95 3.82 3.18 2.18 Other Non Current Assets 1.56 2.54 0.55 0.46 0.32 0.34 0.24 0.28 0.17 0.05 Current Assets 172.47 188.50 181.48 150.35 124.44 104.65 95.12 93.02 84.48 79.08 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 67.55 69.52 66.17 54.37 41.61 35.77 31.71 33.69 33.66 32.21 Sundry Debtors 51.66 65.69 64.06 61.01 56.82 44.99 45.49 43.44 38.19 37.02 Cash & Bank 2.95 4.09 4.02 4.61 4.46 4.54 3.02 4.53 3.03 1.97 Other Current Assets 50.31 2.36 0.23 0.84 21.54 19.35 14.89 11.36 9.61 7.87 Short Term Loans & Adv. 46.64 46.85 47.00 29.53 20.12 18.00 13.96 10.89 9.09 7.52 Net Current Assets 32.52 45.45 48.15 28.03 13.83 12.42 8.35 0.35 -1.83 0.40 Total Assets 239.31 257.16 251.10 218.84 193.33 164.15 154.75 149.84 141.16 135.42

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 11 Mar 10 Mar 09
Shareholder's Funds 52.43 66.64 64.99 62.45 54.90 55.20 50.05 36.18 35.76 37.23 Share Capital 14.17 14.17 14.17 14.17 12.87 12.87 11.11 10.48 10.48 10.48 Total Reserves 38.25 52.47 50.82 48.27 40.01 40.31 37.20 25.50 25.09 26.52 Non-Current Liabilities 33.56 37.85 45.57 30.02 45.12 16.34 17.92 64.54 60.66 52.96 Secured Loans 23.15 28.76 33.25 12.76 15.24 6.11 6.58 53.76 54.41 46.34 Unsecured Loans 0.00 0.00 1.43 5.04 19.71 0.53 1.39 3.97 0.01 0.83 Long Term Provisions 3.62 2.71 2.05 3.42 2.28 1.65 1.06 0.00 0.00 0.00 Current Liabilities 159.49 163.24 154.40 143.24 111.19 92.36 86.77 34.59 27.78 31.47 Trade Payables 38.67 47.34 49.96 54.43 46.85 38.53 33.53 27.02 22.07 22.62 Other Current Liabilities 30.69 27.86 33.77 16.45 12.01 11.86 8.66 6.03 4.73 6.49 Short Term Borrowings 89.63 87.08 68.31 71.07 50.09 40.14 42.75 0.00 0.00 0.00 Short Term Provisions 0.50 0.96 2.37 1.29 2.24 1.83 1.83 1.53 0.99 2.36 Total Liabilities 238.39 261.31 260.17 233.33 211.03 163.87 154.74 135.31 124.20 121.66 Net Block 70.71 70.39 71.48 59.98 56.23 52.20 55.18 54.26 54.98 54.93 Gross Block 97.70 89.76 84.71 66.44 106.10 95.14 90.11 76.86 74.11 67.45 Accumulated Depreciation 27.00 19.37 13.23 6.46 49.87 42.95 34.93 22.60 19.13 12.53 Non Current Assets 77.26 78.26 75.41 68.78 68.03 58.74 59.63 54.40 55.00 55.34 Capital Work in Progress 3.32 3.63 0.21 1.70 3.93 0.77 0.25 0.13 0.00 0.40 Non Current Investment 0.00 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 Long Term Loans & Adv. 1.67 1.69 3.15 6.61 7.54 5.42 3.95 0.00 0.00 0.00 Other Non Current Assets 1.56 2.54 0.55 0.46 0.32 0.34 0.24 0.00 0.00 0.00 Current Assets 161.14 183.05 184.77 164.55 143.00 105.12 95.12 80.90 69.20 61.38 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 67.71 69.75 66.49 54.73 41.75 35.82 31.71 32.21 28.62 23.89 Sundry Debtors 49.60 64.70 64.05 61.80 56.94 44.98 45.49 37.02 31.92 29.29 Cash & Bank 3.13 4.32 4.15 4.71 4.63 5.49 3.02 2.23 1.61 1.49 Other Current Assets 40.69 0.70 0.24 0.86 39.66 18.83 14.89 9.44 7.05 6.73 Short Term Loans & Adv. 40.36 43.58 49.83 42.45 38.45 17.48 13.96 5.56 4.59 3.62 Net Current Assets 1.64 19.81 30.36 21.31 31.81 12.77 8.35 46.31 41.42 29.91 Total Assets 238.40 261.31 260.18 233.33 211.03 163.86 154.75 135.30 124.20 121.66

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 21.57 11.55 12.57 6.36 1.28 14.38 13.31 16.14 12.94 11.29 PBT -9.08 4.41 8.45 8.59 5.18 5.20 6.63 5.09 4.37 1.10 Adjustment 16.55 15.67 15.08 14.73 11.21 11.67 10.43 11.67 10.09 10.13 Changes in Working Capital 14.27 -6.16 -9.69 -15.56 -14.32 -1.18 -2.59 0.87 -1.05 0.08 Cash after chg. in Working capital 21.74 13.92 13.84 7.77 2.08 15.69 14.47 17.63 13.41 11.31 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.17 -2.38 -1.27 -1.40 -0.80 -1.31 -1.16 -1.48 -0.46 -0.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -3.16 -11.98 -15.59 -7.96 -13.73 -6.07 -7.30 -4.02 -2.22 -2.77 Net Fixed Assets -6.22 -4.61 -3.80 41.86 -12.93 -5.24 -7.47 -4.16 -3.99 -2.86 Net Investments 0.02 0.00 -7.42 1.16 -0.09 -1.07 0.00 0.00 0.04 0.00 Others 3.04 -7.37 -4.37 -50.98 -0.71 0.24 0.17 0.14 1.73 0.09 Cash from Financing Activity -19.94 0.05 3.53 1.74 12.38 -6.80 -7.52 -10.62 -9.66 -8.17 Net Cash Inflow / Outflow -1.52 -0.38 0.51 0.15 -0.07 1.51 -1.51 1.51 1.06 0.35 Opening Cash & Equivalents 2.20 2.58 2.07 4.46 4.54 3.02 4.53 3.03 1.97 1.61 Closing Cash & Equivalent 0.68 2.20 2.58 4.61 4.46 4.54 3.02 4.53 3.03 1.97

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 11 Mar 10 Mar 09
Cash From Operating Activity 23.10 7.76 0.58 6.31 -19.35 14.53 13.31 4.61 -5.22 12.89 PBT -13.53 -0.20 2.88 2.87 2.65 4.74 6.63 1.04 -0.91 4.06 Adjustment 18.88 17.41 15.14 14.79 11.46 11.69 10.43 9.49 7.12 6.56 Changes in Working Capital 17.94 -7.07 -16.18 -9.95 -32.66 -0.59 -2.59 -6.10 -10.70 3.29 Cash after chg. in Working capital 23.28 10.13 1.84 7.72 -18.55 15.84 14.47 4.43 -4.48 13.90 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.18 -2.38 -1.27 -1.40 -0.80 -1.31 -1.16 0.18 -0.74 -1.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.71 -8.04 -3.56 -7.96 -13.88 -5.30 -7.30 -1.59 4.61 -11.34 Net Fixed Assets -6.22 -4.61 -3.80 41.86 -12.93 -5.24 -15.62 -2.86 -6.26 -11.18 Net Investments 0.02 0.00 -7.42 1.16 -0.09 -1.07 0.04 0.00 0.03 0.00 Others 1.49 -3.43 7.66 -50.98 -0.86 1.01 8.28 1.27 10.84 -0.16 Cash from Financing Activity -19.97 0.01 3.53 -5.94 32.37 -6.80 -7.52 -2.40 0.74 -2.96 Net Cash Inflow / Outflow -1.58 -0.27 0.55 -7.58 -0.86 2.43 -1.51 0.62 0.13 -1.41 Opening Cash & Equivalents 2.44 2.71 2.16 -17.72 5.49 3.02 4.53 1.61 1.49 2.90 Closing Cash & Equivalent 0.86 2.44 2.71 -25.30 4.63 5.45 3.02 2.23 1.61 1.49

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 46.53 54.23 50.97 46.98 42.48 41.63 43.48 41.06 37.88 34.64 ROA -3.59% 2.66% 2.53% 2.58% 1.57% 2.52% 3.33% 2.94% 2.72% 0.36% ROE -12.47% 9.07% 8.56% 8.76% 5.18% 7.90% 11.06% 10.26% 9.84% 1.31% ROCE 2.09% 9.95% 11.76% 12.77% 10.07% 11.30% 13.77% 13.39% 12.27% 8.55% Fixed Asset Turnover 2.15 3.02 3.05 2.70 2.00 2.04 2.09 1.85 1.83 1.57 Receivable days 125.48 106.15 108.76 92.68 92.06 86.60 89.17 99.15 96.48 107.85 Inventory Days 146.56 111.00 104.83 75.50 69.97 64.59 65.58 81.80 84.52 95.18 Payable days 92.65 88.56 101.97 90.67 90.60 79.18 78.99 85.48 77.58 89.55 Cash Conversion Cycle 179.40 128.58 111.61 77.50 71.43 72.02 75.75 95.48 103.42 113.48 Total Debt/Equity 1.51 1.36 1.25 1.11 1.28 0.92 1.08 1.23 1.43 1.59 Interest Cover 0.29 1.35 1.90 2.02 1.80 1.80 1.93 1.64 1.59 1.16

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 11 Mar 10 Mar 09
Book Value (Rs.) 36.99 47.02 45.86 44.06 41.09 41.32 43.48 34.33 33.94 30.59 ROA -5.16% 0.83% 0.15% -0.18% 0.14% 2.23% 3.50% 0.31% -1.16% 2.60% ROE -21.65% 3.27% 0.59% -0.69% 0.49% 7.00% 12.03% 1.14% -4.22% 9.62% ROCE -0.44% 6.88% 7.45% 7.59% 7.35% 10.88% 14.05% 8.51% 6.31% 11.32% Fixed Asset Turnover 1.83 2.58 2.80 2.72 2.01 2.06 2.18 1.60 1.58 2.12 Receivable days 121.92 104.42 108.60 92.23 91.87 86.58 82.73 104.23 99.58 86.63 Inventory Days 146.63 110.50 104.61 74.94 69.91 64.63 64.10 91.99 85.43 81.22 Payable days 90.28 86.70 99.47 88.16 89.31 79.05 72.93 89.00 77.88 79.60 Cash Conversion Cycle 178.26 128.22 113.74 79.02 72.47 72.17 73.90 107.22 107.13 88.25 Total Debt/Equity 2.26 1.85 1.69 1.49 1.68 0.93 1.08 1.60 1.53 1.47 Interest Cover -0.06 0.98 1.31 1.34 1.41 1.73 1.93 1.15 0.86 1.86

Top Investors:

jitendra tejraj lunia

Annual Reports:

News Update:

Bal Pharma launches Favipiravir formulation into Indian market
25th May 2021, 10:17 AM

Favipiravir inhibits and terminates viral protein synthesis and induces lethal metagenesis of influenza virus
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback